Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties

Bioorganic & Medicinal Chemistry Letters
2000.0

Abstract

A novel series of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones has been prepared. These compounds showed good PDE 4 inhibitory activity and weak affinity for rolipram's binding site. They also exhibited a good anti-inflammatory profile without emetic side effects.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties
Bioorganic & Medicinal Chemistry Letters 2000.0
Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Design, synthesis and in vitro PDE4 inhibition activity of certain quinazolinone derivatives for treatment of asthma
Medicinal Chemistry Research 2012.0
Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics
Bioorganic & Medicinal Chemistry Letters 2003.0
Syntheses and evaluation of pyrido[2,3-d]pyrimidine-2,4-diones as PDE 4 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Aryl sulfonamides as selective PDE4 inhibitors
Bioorganic & Medicinal Chemistry Letters 1998.0
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
Bioorganic & Medicinal Chemistry Letters 2002.0
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma
Bioorganic & Medicinal Chemistry Letters 2002.0
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 2002.0